Biophytis Sa (BPTS)

$8.22

Market is closed - opens 7 PM, 04 Jun 2024

Highlights

Market Capitalization
2.6M
Book Value
$0.0
Earnings Per Share (EPS)
-128.39
Wall Street Target Price
6000.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-52.78%
Return On Equity TTM
-1244.4%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-13.8M
Diluted Eps TTM
-128.39
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Sell
    0
    0%Buy
    37%Hold
    62%Sell
Based on 8 Wall street analysts offering stock ratings for Biophytis Sa(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
3
3
4
Sell
5
5
4

Analyst Forecast

What analysts predicted

Upside of 1724.82%

Current $8.22
Target $150.00

Technicals Summary

Sell

Neutral

Buy

Biophytis Sa is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • Morgan Stanley - Brokerage Accounts

    0.05%
  • Rhumbline Advisers

    0.01%

Company Information

biophytis is a biotech company developping therapeutics for aging diseases. it that has been created in 2006 as a spin-off of université pierre et marie curie (paris). biophytis has developped a portfolio of drug candidates at clinical stage for the treatment of sarcopenic obesity (bio101, bio103) and dry age-related macular degeneration (bio201).

Organization
Biophytis Sa
Employees
22
CEO
Mr. Stanislas Veillet Ph.D.
Industry
Health Technology

FAQs